Halozyme Therapeutics | HALO - Рыночная капитализация





Рыночная капитализация Изменить Дата
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.53B 480M 2026-04
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amarin USD 290M 51M 2025-12
Amgen USD 176.25B 24.32B 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Cara Therapeutics USD 366M 338M 2025-09
Cytokinetics USD 7.77B 1.19B 2025-12
DBV Technologies USD 274M 17M 2025-09
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Ionis Pharmaceuticals USD 10.55B 1.91B 2026-04
MannKind USD 1.74B 93M 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Pfizer USD 141.57B 6.48B 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12